Implant Choice May Reduce the Risk of Early Mechanical Failure in Total Ankle Replacement
Journal of Bone and Joint Surgery · 01.05.2024 · 106 (9) · 767-775
DOI: 10.2106/jbjs.23.00933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 05.03.2024. Verfasst von Jensen K Henry und 8 weiteren Autor:innen. Beteiligte Einrichtung: Foot and Ankle Department, Hospital for Special Surgery, New York, NY. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Ankle, Prosthesis Failure, Reoperation. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Total ankle replacements (TARs) have rapidly advanced in terms of volume, technique, design, and indications. However, TARs are still at risk for early mechanical failure and revision. Prior studies have investigated potential risk factors for failure, but have been limited to smaller series or older implants. This study sought to identify risk factors for early mechanical failure in modern TAR.
Methods
This is a retrospective study of a single-institution registry. Five surgeons contributed cases involving patients who underwent a primary TAR with any implant. Implants were grouped on the basis of the type of fixation. The primary outcome was early mechanical failure (revision with component removal for a non-infectious etiology, that is, subsidence, aseptic loosening, and/or malalignment). Logistic regression determined the effects of age, weight, hindfoot arthrodesis, implant type, and radiographic deformity on failure.
Results
The 731 included patients had a mean follow-up of 2.7 years. Ten percent (71 patients) had hindfoot arthrodesis. There were 33 mechanical failures (4.5%) at a mean of 1.7 years after the index surgical procedure. Our model demonstrated that hindfoot arthrodesis was associated with 2.7 times greater odds of failure (p = 0.045), every 10 kg of body weight increased the odds of tibial-sided failure by 1.29 times (p = 0.039), and implants with more extensive tibial fixation (stems or keels) lowered the odds of tibial failure by 95% (p = 0.031).
Conclusions
In patients with uncontrollable risk factors (hindfoot arthrodesis) or risk factors that may or may not be modifiable by the patient (weight), implants with more robust tibial fixation may be able to reduce the risk of early mechanical failure. Further research is warranted to support efforts to decrease early failure in TAR. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Foot and Ankle Department, Hospital for Special Surgery, New York, NY.
- Duke University School of Medicine, Durham, North Carolina.
- Biostatistics Department, Hospital for Special Surgery, New York, NY.
ORCID-Profile: Jensen K Henry, Isabel Shaffrey, Agnes D Cororaton, Joaquin Palma Munita, Elizabeth Cody, Jonathan Deland, Constantine Demetracopoulos
Zitieren
APA
Henry, J. K., Shaffrey, I., Cororaton, A. D., Munita, J. P., Cody, E., O'Malley, M., Deland, J., Ellis, S., & Demetracopoulos, C. (2024). Implant Choice May Reduce the Risk of Early Mechanical Failure in Total Ankle Replacement. Journal of Bone and Joint Surgery, 106(9), 767-775. https://doi.org/10.2106/jbjs.23.00933
Vancouver
Henry JK, Shaffrey I, Cororaton AD, Munita JP, Cody E, O'Malley M, et al. Implant Choice May Reduce the Risk of Early Mechanical Failure in Total Ankle Replacement. Journal of Bone and Joint Surgery. 2024;106(9):767-775. doi:10.2106/jbjs.23.00933
BibTeX
@article{Henry2024,
author = {Henry, Jensen K and Shaffrey, Isabel and Cororaton, Agnes D and Munita, Joaquin Palma and Cody, Elizabeth and O'Malley, Martin and Deland, Jonathan and Ellis, Scott and Demetracopoulos, Constantine},
title = {Implant Choice May Reduce the Risk of Early Mechanical Failure in Total Ankle Replacement},
journal = {Journal of Bone and Joint Surgery},
year = {2024},
volume = {106},
number = {9},
pages = {767--775},
doi = {10.2106/jbjs.23.00933}
}
EUVIMED